Motley Fool Australia

GID Dynamics Inc enters trading halt: Here’s what you need to know

stop sign

GI Dynamics Inc (ASX: GID) has entered into a trading hold pending a material announcement regarding its business. The shares will be stuck at 30 cents until the commencement of trading on Monday, 9 March 2015, or until an earlier announcement of the material event is made.

So What: GI Dynamics is a medical device maker located in the United States which is focused on the development of non-surgical treatments for patients suffering type 2 diabetes and obesity. While it could be good news, investors are likely nervous about the announcement given that the stock plummeted 39% when it last emerged from a trading halt in October last year.

At the time, GI Dynamics announced a suspension of sales of its main product, EndoBarrier, due to its reporting systems not being up to scratch. Although shipments have since resumed, the company also lost its Chief Financial Officer while roughly 10% of its workforce was let go, indicating things aren’t going so well for the company.

As it stands, the stock has lost 55% of its value over the last 12 months, while it has fallen 72% since peaking in 2012.

Now What: As demonstrated by Sirtex Medical Limited (ASX: SRX), there is potential to make enormous profits in the biotechnology sector when things go according to plan. But for every Sirtex Medical, there are numerous other companies who show plenty of promise yet never manage to succeed.

While it is unclear what GI Dynamics’ announcement will be regarding, investors need to remember the risks involved in investing in the sector. Notably, there are plenty of safer ways to make money in the stock market.

NEW: The Motley Fool’s top stock for 2015 – Yours FREE!

Our TOP healthcare stock is trading at a 30% discount to its highs

If there's one thing for sure, 2020 has been the year we embraced sanitisation. Scott Phillips has discovered a little-known Australian healthcare company could be set to reap the rewards of the post-covid world.

Better yet, this fast-growing company is currently trading at a 30% discount from its highs. Scott believes in this stock so much, he's staked $209k of our own company money on it. Forget 'buy now pay later', this stock could be the next hot stock on the ASX.

Scott and his team have published a detailed report on this tiny ASX stock. Find out how you can access our TOP healthcare stock today!

As of 2.11.2020

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

Related Articles…

Latest posts by Ryan Newman (see all)